PA
RVLV icon

PharVision Advisers’s Revolve Group RVLV Stock Holding History

PharVision Advisers’s Portfolio RVLV Stock Details RVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,178
Closed -$337K – 540
2025
Q4 		$337K Sell
11,178
-10,576
-49% -$255K 0.17% 214
2025
Q3 		$463K Buy
+21,754
New +$474K 0.26% 33

Other funds holding RVLV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

PharVision Advisers's RVLV Position: Q1 2026 in Review

PharVision Advisers sold out of Revolve Group (RVLV) in Q1 2026, closing a stake of 11,178 shares — an estimated $337K sold.

PharVision Advisers first reported a position in RVLV in Q3 2025 and held it in 2 quarters. The position peaked at $463K in Q3 2025. 204 funds tracked by Wall St. Rank hold RVLV as of Q1 2026.

  • PharVision Advisers reported no remaining Revolve Group position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,178 Revolve Group shares in Q1 2026, an estimated $337K.
  • PharVision Advisers first reported a position in Revolve Group in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Revolve Group position peaked at $463K in Q3 2025.
  • 204 funds tracked by Wall St. Rank held Revolve Group as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.